While TNF-targeted blockade had been shown to be effective in treating psoriasis and other autoimmune diseases, IL-6-targeted blockade had not been equally successful6. Whereas the transcriptional control of TNF and IL-6 has been extensively investigated, the post-transcriptional regulation of TNF/IL-6 is less understood. Here, IL6 is linked to autoimmune disease.